You have 9 free searches left this month | to do more

Daratumumab

Daratumumab is a drug used to treat Multiple Myeloma, Plasma Cell Myeloma, AL Amyloidosis, and other conditions. Daratumumab is being actively studied in 118 studies and prior, has been studied in 14.

Top SponsorsTop SitesTop Investigators
Janssen Research & Development, LLCMayo ClinicFernando Fervenza
Mayo ClinicColorado Blood Cancer InstituteAjai Chari
CelgeneHackensack University Medical CenterAjay Nooka
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Recruiting
  • Multiple Myeloma
  • Daratumumab
  • Cologne, Germany
    University of Cologne
2021-08-17
Aug 17, 2021
M
Recruiting
  • Lupus Nephritis
  • Daratumumab
  • Rochester, Minnesota
    Mayo Clinic in Rochester
2021-05-19
May 19, 2021
W
Not yet recruiting
  • Glioblastoma
  • Daratumumab
  • Morgantown, West Virginia
    West Virginia University Cancer Institute Mary Babb Randolph Can
2021-06-25
Jun 25, 2021
A
Not yet recruiting
  • Multiple Myeloma
  • Lenalidomide Pill
  • +2 more
  • (no location specified)
2021-06-02
Jun 2, 2021
A
Not yet recruiting
  • Plasma Cell Leukemia
  • Daratumumab
  • (no location specified)
2021-09-22
Sep 22, 2021
P
Recruiting
  • Amyloidosis; Systemic
  • Daratumumab
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
2021-05-31
May 31, 2021
S
Recruiting
  • Multiple Myeloma
  • Daratumumab
  • Charlotte, North Carolina
    Levine Cancer Institute
2021-10-05
Oct 5, 2021
J
Recruiting
  • Chronic Lymphocytic Leukemia
  • Daratumumab
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
2021-09-07
Sep 7, 2021
B
Completed
  • AL Amyloidosis
  • daratumumab
  • Boston, Massachusetts
    Boston Medical Center
2021-04-15
Apr 15, 2021
F
Completed
  • Membranoproliferative Glomerulonephritis
  • Daratumumab
  • Rochester, Minnesota
    Mayo Clinic
2021-06-28
Jun 28, 2021
C
Active, not recruiting
  • Multiple Myeloma
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2021-11-01
Nov 1, 2021
M
Suspended
  • Plasma Cell Myeloma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +2 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
2021-09-27
Sep 27, 2021
R
Withdrawn
  • Allosensitization
  • Heart Transplant Failure and Rejection
  • Daratumumab
  • (no location specified)
2020-10-26
Oct 26, 2020
W
Recruiting
  • Multiple Myeloma
  • +2 more
  • Daratumumab
  • +3 more
  • New York, New York
    Weill Cornell Medicine - Multiple Myeloma Center
2021-11-18
Nov 18, 2021
W
Recruiting
  • Amyloid
  • +2 more
  • Daratumumab
  • +2 more
  • Palo Alto, California
  • +3 more
2021-06-23
Jun 23, 2021
D
Active, not recruiting
  • Waldenström Macroglobulinemia
  • Daratumumab
  • Boston, Massachusetts
  • +4 more
2021-04-21
Apr 21, 2021
T
Not yet recruiting
  • Newly Diagnosed Multiple Myeloma
  • Daratumumab
  • (no location specified)
2021-10-10
Oct 10, 2021
U
Completed
  • Amyloidosis
  • Daratumumab
  • Angers, France
  • +9 more
2021-07-08
Jul 8, 2021
H
Not yet recruiting
  • Multiple Myeloma
  • Daratumumab
  • +3 more
  • Hackensack, New Jersey
    John Theurer Cancer Center
2021-10-04
Oct 4, 2021
M
Recruiting
  • Recurrent Chronic Lymphocytic Leukemia
  • +4 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
2021-03-03
Mar 3, 2021
W
Recruiting
  • Waldenstrom Macroglobulinemia
  • +6 more
  • New York, New York
    Weill Cornell Medicine
2020-12-22
Dec 22, 2020
H
Recruiting
  • Multiple Myeloma
  • Selinexor 60 MG
  • +6 more
  • Hackensack, New Jersey
    John Theurer Cancer Center
2021-06-04
Jun 4, 2021
U
Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • San Francisco, California
    University of California, San Francisco
2021-05-17
May 17, 2021